Regulus Therapeutics reported $2.79M in Loan Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Alnylam Pharmaceuticals ALNY:US USD 1.02B 338.25M
AstraZeneca AZN:LN USD 23.68B 3.47B
Astrazeneca AZN:US USD 23.68B 3.47B
Biogen BIIB:US USD 6.28B 1.8M
GlaxoSmithKline GSK:LN GBP 19.32B 538M
Intercept Pharmaceuticals ICPT:US USD 222.86M 491M
IONIS PHARMACEUT IONS:US USD 1.25B 1.1M
Omeros OMER:US USD 439.82M 125.46M
Takeda 4502:JP JPY 4.17T 151.94B
YTE INCY:US USD 30.48M 681K